| Literature DB >> 27066782 |
Nong-Rong Wang1, Meng-Meng Wang1, Lv Zhou2, Ze-Lin Liu1,3, Nan-Ping Chen1, Jin-Ping Hu2, Yan-Juan Deng2, Xiao-Qing Qi2, Xiao-Feng Huang2, Yue Su4, Si-Yao Zhang4, Fei Tong4, Yu Zhang4, Qi Lu4, Zi-Yu Zhu4, Huan Deng5,6,7.
Abstract
BACKGROUND: The clear cell/signet-ring cell variant of cutaneous squamous cell carcinoma (cSCC) is extremely rare. Its carcinogenesis has consistently been linked to ultraviolet radiation and HPV in the literature. However, there is little definite information about the contribution of diabetes mellitus (DM) to cSCC. CASEEntities:
Keywords: Clear cell; Diabetes mellitus; HPV; Signet-ring cell; Squamous cell carcinoma
Mesh:
Substances:
Year: 2016 PMID: 27066782 PMCID: PMC4827219 DOI: 10.1186/s13000-016-0487-1
Source DB: PubMed Journal: Diagn Pathol ISSN: 1746-1596 Impact factor: 2.644
Fig. 1Clinical and histological findings of clear cell/signet ring cell cSCC. A mushroom-like lesion in right thigh was resected under local anesthesia (a, b). Scars caused by chronic ulcer were observed adjacent to the lesion (a, black arrow). Clear cell/signet ring cell assembled thick trabecula and solid nest (c, original magnification × 20). Scattered signet ring cells were observed (d, black arrow, original magnification × 400)
Summary of Primary Antibodies Used for Immunohistochemistry
| Antibody | Supplier | Dilution |
|---|---|---|
| Cytokeratin | DAKO | 1:100 |
| Cytokeratin 5/6 | DAKO | 1:100 |
| Cytokeratin 7 | DAKO | 1:100 |
| Cytokeratin 8 | DAKO | 1:150 |
| Cytokeratin 14 | DAKO | 1:150 |
| Cytokeratin 18 | DAKO | 1:100 |
| Cytokeratin 19 | DAKO | 1:100 |
| Cytokeratin 20 | DAKO | 1:100 |
| c-erbB-2 | DAKO | 1:100 |
| P16 | abcam | 1:150 |
| P53 | abcam | 1:100 |
| P63 | abcam | 1:100 |
| FGFR2 | abcam | 1:150 |
Fig. 2Histochemical and immunohistochemical profiles of clear cell/signet-ring cell SCC. The lesion was composed of diffused clear cells/signet cells (a, original magnification × 400). The septa of clear cells/signet-ring cells in serial sections were positive for PAS (b, original magnification × 400). They also expressed cytokeratin AE1/AE3, CK5/6, CK14, and CK19 (c–f, original magnification × 400). The lesion did not exhibit mutations of p53 (g, original magnification × 400). P63 positivity was detected in the nuclei of malignant cells (h, original magnification × 400). Clear cells/signet cells expressed strong-diffuse reactivity for FGFR2, a downstream effector of p63 (i, original magnification × 400). Less than 5 % of cancer cells expressed Ki-67 (j, original magnification × 400)
Fig. 3The results of HPV type-specific PCR and genotyping indicated that the patient was negative for infection with HPV
Summary of cutaneous squamous cell lesions with clear cell/signet-ring cell morphology
| Case | Age/Sex | Pathologic Diagnosis | Location | HC | IHC | Etiology | EM | Reference | ||
|---|---|---|---|---|---|---|---|---|---|---|
| positive | negative | positive | negative | |||||||
| 1 | 69/M | SRSCC | forehead | N/A | Kreyberg Stain | keratin | N/A | N/A | N/A | 11 |
| 2 | 50/M | SRSCC | neck | PAS (septum between vacuoles) | Mucicarmine, PAS (vacuoles) | AE1/AE3, MAK 6 Ker, Ker 903, CAM 5.2, CEA (weak), EMA (weak), Ki-67 | Leu M1, S-100, HMB-45, Actin, Vimentin, SMA | Not done | Rough ER cisternal dilatation | 9 |
| 3 | 79/F | SCC | right cheek | No | colloical iron, PAS | cytokeratin | No | not done | no stained material | 12 |
| 4 | 82/M | SCC | left temple | No | colloical iron, PAS | cytokeratin | No | Not done | no stained material | |
| 5 | 83/M | SCC | right ear | No | colloical iron, PAS | cytokeratin | No | Not done | no stained material | |
| 6 | 80/M | SCC | forehead | No | colloical iron, PAS | cytokeratin | No | Not done | no stained material | |
| 7 | 87/M | SCC | frontal scalp | No | colloical iron, PAS | cytokeratin | No | Not done | no stained material | |
| 8 | 76/M | SCC | forehead | No | colloical iron, PAS | cytokeratin | No | Not done | no stained material | |
| 9 | 84/F | SRSCC | upper lip | No | mucicarmine, PAS | keratin, P63, EMA | No | Not done | Not done | 13 |
| 10 | 66/F | SCC | sole | AB, colloidal iron, | PAS | AE1/AE3, EMA, CK5/6 | CK7, CK20, CEA, BerEP4, S100, Her2, ER, Ki-67 | HPV 18 | Not done | 5 |
| 11 | 67/M | SCC | left lateral canthus | No | AB, mucicarmine, PAS | CK5/6, p63, EMA | CK7, Ck20, CEA | Not done | Not done | 2 |
| 12 | 83/M | SRSCC | back of finger | No | Mucicarmine, PAS | No | CK20, CEA, vimentin, HMB45, Melan A, desmin | not done | not done | 14 |
| 13 | 62/M | CCSCC | left side of face | No | PAS mucicarmine, AB | AE1/AE3 | No | N/A | N/A | 15 |
| 14 | 78/F | CC/SRSCC | right thigh | PAS | N/A | AE1/AE3, CK5/6, CK14, CK19, p63, FGFR2 | CK7, CK8, CK18, CK20, P16, HER-2, p53, Ki-67 | No HPV infection | Not done | present study |
HC histochemistry; IHC immunohistochemistry; EM electron microscopy; SCC squamous cell carcinoma; SRSCC signet ring cell squamous cell carcinoma; CCSCC clear cell squamous cell carcinoma; CC/SRSCC clear cell/signet ring cell squamous cell carcinoma; PAS periodic-acid Schiff; CCS clear cell sarcoma; MiTF microphthalmia transcription factor; CCSCC clear cell/signet ring cell squamous cell carcinoma
Fig. 4Hypothesis regarding the involvement of type 2 DM in the pathogenesis of cSCC. Epidemiological studies suggest that hyperglycemia, hyperinsulinemia, and immune disorders in patients with type 2 DM increase the risk of malignant transformation. DM-related chronic ulcer is proposed as a precancerous lesion. Type 2 DM can enhance the expression of p63, which in turn activate the downstream element FGFR2. It may also increase the secretion of FGF7 in stromal cells and affect FGFR2 through paracrine stimulates. Indirect evidence indicates that PI3K/AKT signaling may be involved and contribute to the malignant transformation of squamous cell